[artículo]
| Título : |
Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder |
| Tipo de documento: |
texto impreso |
| Autores: |
Elias Eriksson, Autor ; Agneta Ekman, Autor ; Suzanne Sinclair, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 195-202. |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Citalopram, Relación Dosis-Respuesta, Libido, Náuseas, Síndrome Premenstrual - terapia farmacológica. |
| Resumen: |
This is the first placebo-controlled trial evaluating the efficacy of the selective serotonin reuptake inhibitor (SSRI), escitalopram, in the treatment of premenstrual dysphoric disorder (PMDD). Women with PMDD (intention-to-treat population, n = 151) were treated intermittently for 3 months, during luteal phases only, with 10 mg/d escitalopram, 20 mg/d escitalopram, or placebo. |
| Link: |
./index.php?lvl=notice_display&id=30863 |
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 2 (Abril) . - pp. 195-202.
[artículo] Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder [texto impreso] / Elias Eriksson, Autor ; Agneta Ekman, Autor ; Suzanne Sinclair, Autor . - 2023 . - pp. 195-202. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 2 (Abril) . - pp. 195-202.
| Palabras clave: |
Citalopram, Relación Dosis-Respuesta, Libido, Náuseas, Síndrome Premenstrual - terapia farmacológica. |
| Resumen: |
This is the first placebo-controlled trial evaluating the efficacy of the selective serotonin reuptake inhibitor (SSRI), escitalopram, in the treatment of premenstrual dysphoric disorder (PMDD). Women with PMDD (intention-to-treat population, n = 151) were treated intermittently for 3 months, during luteal phases only, with 10 mg/d escitalopram, 20 mg/d escitalopram, or placebo. |
| Link: |
./index.php?lvl=notice_display&id=30863 |
|
Refinar búsquedaEscitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 2 (Abril)
